Nemolizumab-Ilto

Common brands: Nemluvio, Dupixent, Vitamin D, Allergy Relief, Allergy Nasal

Top reporter: Galderma Laboratories, L.P.

Interleukin-31 Receptor alpha Antagonist [EPC]Interleukin-4 Receptor alpha Antagonist [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Provitamin D2 Compound [EPC]
9,893
Total Reports
9,880
Serious Reports
80
Death Reports
30
Reported Reactions
Death Report Ratio: Low (0.81%)

Patient Demographics

Male
161
Female
339

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Nemolizumab-Ilto.

# Reaction Reports % of Total
1 PRODUCT DOSE OMISSION ISSUE 3,056
22.7%
2 DEVICE MALFUNCTION 1,634
12.1%
3 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1,431
10.6%
4 INCORRECT DOSE ADMINISTERED 1,036
7.7%
5 PRURITUS 994
7.4%
6 RASH 651
4.8%
7 DRUG INEFFECTIVE 536
4.0%
8 HEADACHE 345
2.6%
9 DERMATITIS ATOPIC 334
2.5%
10 DEVICE LEAKAGE 291
2.2%
11 ECZEMA 262
1.9%
12 DEVICE USE ISSUE 250
1.9%
13 DRY SKIN 223
1.7%
14 NEURODERMATITIS 222
1.6%
15 ARTHRALGIA 216
1.6%
16 ERYTHEMA 205
1.5%
17 SKIN EXFOLIATION 183
1.4%
18 INTENTIONAL PRODUCT USE ISSUE 172
1.3%
19 URTICARIA 156
1.2%
20 INJECTION SITE HAEMORRHAGE 147
1.1%
21 RASH PAPULAR 147
1.1%
22 HYPERSENSITIVITY 146
1.1%
23 DEVICE USE ERROR 132
1.0%
24 CONDITION AGGRAVATED 118
0.9%
25 PAIN 116
0.9%
26 MYALGIA 105
0.8%
27 INJECTION SITE PAIN 101
0.8%
28 OFF LABEL USE 89
0.7%
29 BLISTER 85
0.6%
30 SKIN DISCOLOURATION 83
0.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.